EUVIMEDEUVIMED entdecken
Open Access

Cardiomyocyte-Specific RNF128 Attenuates Pathological Cardiac Hypertrophy Progression by Stabilizing SERCA2a through Lys63-Linked Polyubiquitination

Yujie Zhang, Xuehan Liu, Liwen Yu, Changhao Liu, Jingwei Li, Qingmei Han, Xiaohong Wang, Lei Cao, Liangyu Cai, Linqi Jiao, Guohai Su, Meng Zhang und 1 weitere

Theranostics · 2026

DOI: 10.7150/thno.133221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Yujie Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Cardiovascular Remodeling and Function Research, Shandong University Qilu Hospital, No. 107, Wenhua Xi Road, Jinan 250012, Shandong…. Hauptthemen laut MEDLINE: Cardiomegaly, Myocytes, Cardiac, Ubiquitin-Protein Ligases, Sarcoplasmic Reticulum Calcium-Transporting ATPases. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomegalyMyocytes, CardiacUbiquitin-Protein LigasesSarcoplasmic Reticulum Calcium-Transporting ATPasesAnimalsMiceHumansUbiquitinationMice, KnockoutDisease Models, AnimalMaleLysineDisease Progression

Stichwörter der Autor:innen

E3 ubiquitin ligaseautophagycardiac hypertrophyheart failurelysosomal degradation

Substanzen

Ubiquitin-Protein LigasesSarcoplasmic Reticulum Calcium-Transporting ATPasesLysine

Autor:innen und Institutionen

  • Key Laboratory of Cardiovascular Remodeling and Function Research, Shandong University Qilu Hospital, No. 107, Wenhua Xi Road, Jinan 250012, Shandong, China.
  • Cardiovascular Disease Research Center of Shandong First Medical University, Central Hospital Affiliated to Shandong First Medical University, No. 105, Jiefang Road, Jinan 250013, China.
  • Dongying People's Hospital, No. 317, Nanyi Road, Dongying, Shandong 257091, China.

Zitieren

APA

Zhang, Y., Liu, X., Yu, L., Liu, C., Li, J., Han, Q., Wang, X., Cao, L., Cai, L., Jiao, L., Su, G., Zhang, M., & Zhang, C. (2026). Cardiomyocyte-Specific RNF128 Attenuates Pathological Cardiac Hypertrophy Progression by Stabilizing SERCA2a through Lys63-Linked Polyubiquitination. Theranostics. https://doi.org/10.7150/thno.133221

Vancouver

Zhang Y, Liu X, Yu L, Liu C, Li J, Han Q, et al. Cardiomyocyte-Specific RNF128 Attenuates Pathological Cardiac Hypertrophy Progression by Stabilizing SERCA2a through Lys63-Linked Polyubiquitination. Theranostics. 2026. doi:10.7150/thno.133221

BibTeX
@article{Zhang2026,
  author = {Zhang, Yujie and Liu, Xuehan and Yu, Liwen and Liu, Changhao and Li, Jingwei and Han, Qingmei and Wang, Xiaohong and Cao, Lei and Cai, Liangyu and Jiao, Linqi and Su, Guohai and Zhang, Meng and Zhang, Cheng},
  title = {Cardiomyocyte-Specific RNF128 Attenuates Pathological Cardiac Hypertrophy Progression by Stabilizing SERCA2a through Lys63-Linked Polyubiquitination},
  journal = {Theranostics},
  year = {2026},
  doi = {10.7150/thno.133221}
}
Kostenlos starten →